| Ident. | Authors (with country if any) | Title |
|---|
| 000004 (2020) |
Yu-Shi Zhang [République populaire de Chine] ; Wei-Hong Cong [République populaire de Chine] ; Jing-Jing Zhang [République populaire de Chine] ; Fei-Fei Guo [République populaire de Chine] ; Hong-Mei Li [République populaire de Chine] | [Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus]. |
| 000008 (2020) |
H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine] | [Potential antiviral therapeutics for 2019 Novel Coronavirus]. |
| 000009 (2020) |
B. Du [République populaire de Chine] ; H B Qiu [République populaire de Chine] ; X. Zhan [République populaire de Chine] ; Y S Wang [République populaire de Chine] ; H Y J. Kang [République populaire de Chine] ; X Y Li [République populaire de Chine] ; F. Wang [République populaire de Chine] ; B. Sun [République populaire de Chine] ; Z H Tong [République populaire de Chine] | [Pharmacotherapeutics for the New Coronavirus Pneumonia]. |
| 000012 (2020) |
E. Davenne [Belgique] ; J B Giot [Belgique] ; P. Huynen [Belgique] | [Coronavirus and COVID-19 : focus on a galopping pandemic]. |
| 000019 (2020) |
H Y Tian [République populaire de Chine] | [2019-nCoV: new challenges from coronavirus]. |
| 000021 (2020) |
Zi-Wei Ye [Hong Kong] ; Shuofeng Yuan [Hong Kong] ; Kit-San Yuen [Hong Kong] ; Sin-Yee Fung [Hong Kong] ; Chi-Ping Chan [Hong Kong] ; Dong-Yan Jin [Hong Kong] | Zoonotic origins of human coronaviruses |
| 000022 (2020) |
Catrin Sohrabi [Royaume-Uni] ; Zaid Alsafi [Royaume-Uni] ; Niamh O'Neill [Royaume-Uni] ; Mehdi Khan [Royaume-Uni] ; Ahmed Kerwan [Royaume-Uni] ; Ahmed Al-Jabir [Royaume-Uni] ; Christos Iosifidis [Royaume-Uni] ; Riaz Agha [Royaume-Uni] | World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) |
| 000026 (2020) |
Yuefei Jin [République populaire de Chine] ; Haiyan Yang [République populaire de Chine] ; Wangquan Ji [République populaire de Chine] ; Weidong Wu [République populaire de Chine] ; Shuaiyin Chen [République populaire de Chine] ; Weiguo Zhang [République populaire de Chine] ; Guangcai Duan [République populaire de Chine] | Virology, Epidemiology, Pathogenesis, and Control of COVID-19. |
| 000029 (2020) |
Xiao-Li Qiang ; Peng Xu ; Gang Fang ; Wen-Bin Liu ; Zheng Kou | Using the spike protein feature to predict infection risk and monitor the evolutionary dynamic of coronavirus |
| 000036 (2020) |
Mary E. Wilson [États-Unis] ; Lin H. Chen [États-Unis] | Travellers give wings to novel coronavirus (2019-nCoV). |
| 000044 (2020) |
Yan-Rong Guo ; Qing-Dong Cao ; Zhong-Si Hong ; Yuan-Yang Tan ; Shou-Deng Chen ; Hong-Jun Jin ; Kai-Sen Tan [Singapour] ; De-Yun Wang [Singapour] ; Yan Yan | The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status |
| 000045 (2020) |
Carlo Contini [Italie] ; Mariachiara Di Nuzzo [Italie] ; Nicole Barp [Italie] ; Aurora Bonazza [Italie] ; Roberto De Giorgio [Italie] ; Mauro Tognon [Italie] ; Salvatore Rubino [Italie] | The novel zoonotic COVID-19 pandemic: An expected global health concern. |
| 000050 (2020) |
Yongshi Yang [République populaire de Chine] ; Fujun Peng [République populaire de Chine] ; Runsheng Wang [République populaire de Chine] ; Kai Guan [République populaire de Chine] ; Taijiao Jiang [République populaire de Chine] ; Guogang Xu [République populaire de Chine] ; Jinlyu Sun [République populaire de Chine] ; Christopher Chang [États-Unis] | The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China |
| 000060 (2020) |
Yuxin Yan [République populaire de Chine] ; Woo In Shin [Malaisie] ; Yoong Xin Pang [République populaire de Chine] ; Yang Meng [République populaire de Chine] ; Jianchen Lai [République populaire de Chine] ; Chong You [République populaire de Chine] ; Haitao Zhao [États-Unis] ; Edward Lester [Royaume-Uni] ; Tao Wu [République populaire de Chine] ; Cheng Heng Pang [République populaire de Chine] | The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment. |
| 000094 (2020) |
Lisa E. Gralinski [États-Unis] ; Vineet D. Menachery [États-Unis] | Return of the Coronavirus: 2019-nCoV. |
| 000106 (2020) |
Shi Zhao [République populaire de Chine] ; Qianyin Lin [États-Unis] ; Jinjun Ran [République populaire de Chine] ; Salihu S. Musa [République populaire de Chine] ; Guangpu Yang [République populaire de Chine] ; Weiming Wang [République populaire de Chine] ; Yijun Lou [République populaire de Chine] ; Daozhou Gao [République populaire de Chine] ; Lin Yang [République populaire de Chine] ; Daihai He [République populaire de Chine] ; Maggie H. Wang [République populaire de Chine] | Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak |
| 000109 (2020) |
Lei Zhang [République populaire de Chine] ; Yunhui Liu [République populaire de Chine] | Potential interventions for novel coronavirus in China: A systematic review. |
| 000111 (2020) |
David A. Schwartz [États-Unis] ; Ashley L. Graham | Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections |
| 000118 (2020) |
Balamurugan Shanmugaraj [Thaïlande] ; Konlavat Siriwattananon [Thaïlande] ; Kittikhun Wangkanont [Thaïlande] ; Waranyoo Phoolcharoen [Thaïlande] | Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). |
| 000123 (2020) |
Jia Liu [République populaire de Chine] ; Xin Zheng [République populaire de Chine] ; Qiaoxia Tong [République populaire de Chine] ; Wei Li [République populaire de Chine] ; Baoju Wang [République populaire de Chine] ; Kathrin Sutter [Allemagne] ; Mirko Trilling [Allemagne] ; Mengji Lu [Allemagne] ; Ulf Dittmer [Allemagne] ; Dongliang Yang [République populaire de Chine] | Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. |
| 000136 (2020) |
Shengwei Yu [République populaire de Chine] ; Junwu Wang [République populaire de Chine] ; Haitao Shen [République populaire de Chine] | Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19. |
